ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 69 filers reported holding ARCELLX INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $73,143,426 | +16.0% | 2,038,557 | +2.2% | 0.00% | +100.0% |
| Q2 2023 | $63,068,840 | +43.5% | 1,994,587 | +39.8% | 0.00% | 0.0% |
| Q1 2023 | $43,964,514 | -4.6% | 1,426,956 | -4.0% | 0.00% | 0.0% |
| Q4 2022 | $46,062,737 | +98.6% | 1,486,854 | +20.4% | 0.00% | 0.0% |
| Q3 2022 | $23,189,000 | +92.3% | 1,235,387 | +85.2% | 0.00% | – |
| Q2 2022 | $12,060,000 | +96.1% | 667,091 | +52.1% | 0.00% | – |
| Q1 2022 | $6,151,000 | – | 438,722 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 5,500,007 | $99,440,000 | 48.67% |
| AJU IB Investment Co., Ltd. | 1,380,890 | $24,966,000 | 48.34% |
| NEA Management Company, LLC | 6,750,264 | $112,703,000 | 5.79% |
| Samsara BioCapital, LLC | 1,063,835 | $19,234,000 | 5.13% |
| Novo Holdings A/S | 4,016,878 | $72,625,000 | 3.58% |
| CLOUGH CAPITAL PARTNERS L P | 1,165,533 | $20,953,000 | 2.60% |
| Soleus Capital Management, L.P. | 909,739 | $16,448,000 | 2.57% |
| CAXTON CORP | 101,719 | $1,839,000 | 2.47% |
| Cormorant Asset Management, LP | 1,525,000 | $27,572,000 | 2.08% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,470,559 | $44,668,000 | 1.70% |